单孔经膀胱机器人辅助单纯前列腺切除术:手术技术与临床结局
研究在学术医院由两位术者于2019至2023年完成117例单孔经膀胱机器人辅助单纯前列腺切除术,分析随访至少12个月的患者数据。结果显示中位控制台时间107分钟、估计出血量100毫升、输血率0%,95.8%患者在24小时内出院,术后1年国际前列腺症状评分和尿流率持续改善。作者认为该术式是治疗严重良性前列腺增生的可行替代方案,可促进快速康复。
要点
- 单孔经膀胱机器人辅助单纯前列腺切除术通过单个3厘米耻骨上切口完成腺瘤剜除和360°膀胱黏膜瓣重建。
- 117例中无中转增加穿刺孔或开放手术,中位控制台时间107分钟、估计出血量100毫升、输血率0%。
- 95.8%患者24小时内出院,中位住院时间5小时、疼痛评分3/10,术后1年排尿功能持续改善。
核心结论
- 单孔经膀胱机器人辅助单纯前列腺切除术是治疗严重良性前列腺增生的可行替代方案,可促进快速康复并在1年时显示排尿功能改善。
研究设计与样本
- 单孔经膀胱机器人辅助单纯前列腺切除术病例在学术医院由两位术者于2019年至2023年完成,共117例,分析随访至少12个月的患者数据。
- 纳入标准为因前列腺体积大于80毫升导致严重梗阻性排尿症状或依赖导尿管的尿潴留。
主要发现
- 所有手术均成功完成,未增加穿刺孔或中转开放手术。
- 中位控制台时间和估计出血量分别为107分钟和100毫升,输血率为0%。
- 术中并发症包括两例疑似气体栓塞,归因于高充气压力;无重大术后并发症。
- 95.8%患者在最初24小时内出院,中位住院时间和疼痛评分分别为5小时和3/10。
- 术后1年国际前列腺症状评分和尿流率中位数持续改善,12个月时男性性健康量表评分中位数为20。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究受限于其回顾性性质和队列规模。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical management of large prostatic adenomas can be performed via open, endoscopic, or robotic approaches. A low-profile single-port (SP) robot was built to work in confined areas (ie, the bladder) and regionalize surgery. OBJECTIVE: To describe the novel SP transvesical (TV) robot-assisted simple prostatectomy (RASP) and report clinical outcomes. DESIGN, SETTING, AND PARTICIPANTS: SP TV RASP cases were performed in an academic hospital by two surgeons from 2019 to 2023. A total of 117 cases were performed, and data from patients with at least 12 mo of follow-up were analyzed. The inclusion criterion was severe obstructive urinary symptoms or catheter-dependent urinary retention due to large prostates with volume >80 ml. SURGICAL PROCEDURE: The procedure consisted of two main steps through a single 3-cm suprapubic incision: first, enucleation of the adenoma, and second, a 360° bladder mucosal flap reconstruction. No drains or continuous bladder irrigation was used routinely. MEASUREMENTS: Intraoperative parameters, pre- and postoperative uroflowmetry, and 1-yr clinical outcomes were assessed. We used descriptive statistics to analyze the data. RESULTS AND LIMITATIONS: All procedures were completed successfully without additional ports or conversions. The median console time and estimated blood loss were 107 min and 100 ml, respectively. Transfusion rate was 0%. Intraoperative complications included two suspected air emboli attributed to high insufflation pressures. There were no major postoperative complications. In total, 95.8% were discharged within the first 24 h, with a median length of stay and pain score of 5 h and 3/10, respectively. There was persistent improvement in the median International Prostate Symptom Score and flow rate after 1 yr. The median Sexual Score Inventory for Men score was 20 at 12 mo. Our study is limited by its retrospective nature and cohort size. CONCLUSIONS: SP TV RASP is a feasible alternative for the management of severe benign prostatic hyperplasia that promotes fast recovery and demonstrates 1-yr improvement in urinary function. PATIENT SUMMARY: Single-port transvesical robot-assisted simple prostatectomy is a minimally invasive alternative for the treatment of large benign prostatic growth. A single robotic arm goes through a small incision in the skin and bladder to extract the obstructive prostatic tissue. Afterward, reconstruction of the area is done to decrease bleeding and improve postoperative symptoms. We found that patients recover quickly and have excellent clinical results with a low risk of complications.
引用
- Ramos R, Ferguson E, Abou Zeinab M, et al. Single-port Transvesical Robot-Assisted Simple Prostatectomy: Surgical Technique and Clinical Outcomes. Eur Urol. 2023. PMID: 38057210. doi:10.1016/j.eururo.2023.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。